Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.

作者: Jenny H. Zheng , Jack Cook , Melanie R. Nicol , Abhay Joshi , Matthew L. Rizk

DOI: 10.1002/CPT.1993

关键词:

摘要: Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria. To date, these medications not approved for the treatment of viral infections, there no well-controlled, prospective, randomized clinical studies or evidence support their use in patients with coronavirus disease 2019 (COVID-19). Nevertheless, chloroquine being studied alone combination other agents assess effectiveness prophylaxis COVID-19. The effective any medication involves an understanding its pharmacokinetics, safety, mechanism action. This work provides basic pharmacology information relevant planning initiating COVID-19 hydroxychloroquine, summarizes safety data from healthy volunteer studies, phase II II/III uncomplicated malaria, including a study pediatric following administration azithromycin combination. In addition, this presents describing proposed mechanisms action against severe acute respiratory distress syndrome coronavirus-2 efficacy date.

参考文章(114)
Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom, Effects of Antimalarials on the Pharmacokinetics of Co-Administered Antimalarials Adis, Cham. pp. 87- 117 ,(2015) , 10.1007/978-3-319-10527-7_6
Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom, Effects of Antimalarials on the Pharmacokinetics of Co-Administered Drugs Adis, Cham. pp. 57- 85 ,(2015) , 10.1007/978-3-319-10527-7_5
V Amla, K L Gupta, G Bano, R K Raina, V Kapoor, THE EFFECT OF ASPIRIN, PARACETAMOL AND ANALGIN ON PHARMACOKINETICS OF CHLOROQUINE Indian journal of physiology and pharmacology. ,vol. 37, pp. 229- 231 ,(1993)
Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom, Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials Adis, Cham. pp. 17- 25 ,(2015) , 10.1007/978-3-319-10527-7_3
Hong-wei Fan, Zhi-xiang Ma, Jing Chen, Xing-ye Yang, Jun-lin Cheng, Ying-bin Li, Pharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC-MS/MS. Rheumatology and Therapy. ,vol. 2, pp. 183- 195 ,(2015) , 10.1007/S40744-015-0012-0
Julie Ducharme, Robert Farinotti, Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clinical Pharmacokinectics. ,vol. 31, pp. 257- 274 ,(1996) , 10.2165/00003088-199631040-00003
Ann K. Miller, Emma Harrell, Li Ye, Sharon Baptiste-Brown, Jőrg-Peter Kleim, Colin Ohrt, Stephan Duparc, Jörg J. Möhrle, Alison Webster, Sandra Stinnett, Arlene Hughes, Sandy Griffith, Andrew P. Beelen, Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects British Journal of Clinical Pharmacology. ,vol. 76, pp. 858- 867 ,(2013) , 10.1111/BCP.12160
Moez Jallouli, Lionel Galicier, Noel Zahr, Olivier Aumaitre, Camille Frances, Veronique Le Guern, F Lioté, Amar Smail, Nicolas Limal, Laurent Perard, Helene Desmurs‐Clavel, D Le Thi Huong, B Asli, J‐E Kahn, Jacques Pourrat, Laurent Sailler, Felix Ackermann, Thomas Papo, Karim Sacre, Olivier Fain, Jerome Stirnemann, Patrice Cacoub, Gaelle Leroux, Judith Cohen‐Bittan, Jeremie Sellam, Xavier Mariette, B Blanchet, JS Hulot, Zahir Amoura, Jean-Charles Piette, Nathalie Costedoat‐Chalumeau, Plaquenil Lupus Systemic Study Group, Leonardo Astudillo, Cristina Belizna, Nadia Belmatoug, Olivier Benveniste, Audrey Benyamine, Holly Bezanahary, Patrick Blanco, Olivier Bletry, Bahram Bodaghi, Pierre Bourgeois, Benoît Brihaye, Emmanuel Chatelus, Richard Damade, Eric Daugas, Christian De‐Gennes, Jean‐François Delfraissy, Céline Delluc, Aurélien Delluc, Pierre Duhaut, Alain Dupuy, Isabelle Durieu, Hang‐Korng Ea, Dominique Farge, Christian Funck‐Brentano, Frédérique Gandjbakhch, Justine Gellen‐Dautremer, Pascale Ghillani‐Dalbin, Bertrand Godeau, Cécile Goujard, Catherine Grandpeix, Claire Grange, Lamiae Grimaldi, Gaëlle Guettrot, Loïc Guillevin, Eric Hachulla, Jean‐Robert Harle, Julien Haroche, Pierre Hausfater, Jean Jouquan, Gilles Kaplanski, Homa Keshtmand, Mehdi Khellaf, Olivier Lambotte, David Launay, Philippe Lechat, Hervé Levesque, Olivier Lidove, Eric Liozon, Kim Ly, Matthieu Mahevas, Kubéraka Mariampillai, Alexis Mathian, Karin Mazodier, Marc Michel, Nathalie Morel, Luc Mouthon, Lucile Musset, Rokiya Ngack, Jacques Ninet, Eric Oksenhendler, Jean‐Luc Pellegrin, Olivier Peyr, Anne‐Marie Piette, Vincent Poindron, Fabienne Roux, David Saadoun, Sabrinel Sahali, Bernadette Saint‐Marcoux, Françoise Sarrot‐Reynauld, Yoland Schoindre, Damien Sene, Jacques Serratrice, Aude Servais, Pascal Seve, Jean Sibilia, Claude Simon, Christelle Sordet, Benjamin Terrier, Salim Trad, Jean‐François Viallard, Elisabeth Vidal, Bertrand Wechsler, Pierre‐Jean Weiller, Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis & Rheumatism. ,vol. 67, pp. 2176- 2184 ,(2015) , 10.1002/ART.39194
J. Ducharme, H. Fieger, MP Ducharme, SK Khalil, IW Wainer, Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects [see comments] British Journal of Clinical Pharmacology. ,vol. 40, pp. 127- 133 ,(1995) , 10.1111/J.1365-2125.1995.TB05768.X
Susan E Tett, Richard O Day, Joanne Beal, Samantha J Carmichael, Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. The Journal of Rheumatology. ,vol. 29, pp. 2077- 2083 ,(2002)